United States Nutrigenomics Market, By Application (Obesity, Cardiovascular Diseases, Cancer Research, Others), By Product (Reagents & Kits, Services), By Technique (Saliva, Buccal Swab, Blood), By End User (Hospitals & Clinics, Others), By Region, Competition, Forecast & Opportunities, 2021-2031F

Key Insights	Details
Forecast Period	2027-2031
Market Size (2025)	USD 215.95 Million
CAGR (2026-2031)	13.84%
Fastest Growing Segment	Cancer Research
Largest Market	West
Market Size (2031)	USD 470.03 Million

Market Overview

The United States Nutrigenomics Market will grow from USD 215.95 Million in 2025 to USD 470.03 Million by 2031 at a 13.84% CAGR. The United States nutrigenomics market encompasses commercial products and services that apply genomic, epigenomic, and microbiome data to personalize dietary supplement formulations, functional food recommendations, and nutritional intervention protocols, aiming to optimize individual health outcomes. Market expansion is primarily driven by the escalating demand for personalized nutrition solutions that acknowledge individual genetic variability, the rising prevalence of chronic lifestyle-related diseases such as obesity and diabetes, and continuous advancements in genomic research and technology. These advancements have notably reduced genetic sequencing costs and improved the precision of genetic analysis. According to the Council for Responsible Nutrition, in 2024, 69% of supplement users emphasized the importance of a personalized regimen when selecting their products, highlighting a key market impetus.

However, a significant challenge impeding market growth is the high cost and limited accessibility of comprehensive genetic testing services, which frequently lack coverage by health insurance providers. This financial barrier, coupled with the complex and evolving regulatory landscape surrounding genetic data privacy and the absence of unified global standards, creates uncertainty for both providers and consumers, constraining broader adoption.

Key Market Drivers

Demand for Personalized Nutrition and DTC Genetic Testing
Rising consumer demand for personalized nutrition profoundly influences the United States nutrigenomics market by fostering a shift from generic dietary advice to tailored health solutions. Individuals are increasingly seeking specific nutritional guidance informed by their unique genetic profiles to optimize wellbeing and prevent disease. This burgeoning interest translates into higher engagement with direct-to-consumer genetic testing services, which serve as a gateway to nutrigenomic insights. According to the U.S. Food and Drug Administration, in October 2025, there was a 30% increase in direct-to-consumer genetic testing adoption, demonstrating a clear market impetus for personalized health approaches. This trend emphasizes the consumer's desire for precision in dietary recommendations.

Chronic Disease Burden Drives Nutrigenomics Investment
The increasing prevalence of chronic diseases further accelerates the United States nutrigenomics market by highlighting the limitations of conventional disease management and prevention strategies. Conditions such as obesity, diabetes, and cardiovascular disorders are often linked to diet and lifestyle, driving individuals and healthcare providers to explore more effective, individualized interventions. Nutrigenomics offers a proactive approach by identifying genetic predispositions and crafting nutritional plans to mitigate disease risk or manage existing conditions. According to the Physicians Committee for Responsible Medicine, in December 2025, in 23 U.S. states, more than one in three adults was obese, underscoring the pressing need for novel health solutions. This imperative has stimulated investment in the sector; for example, according to Next Gen Nutrition Investments, in March 2026, one nutrition company secured a $20 million investment.

Download Free Sample Report

Key Market Challenges

Cost and Coverage Barriers for Genetic Testing Impede Nutrigenomics Growth
A significant impediment to the growth of the United States nutrigenomics market is the substantial cost and restricted accessibility of comprehensive genetic testing services. These services, fundamental to personalized dietary recommendations and nutritional interventions, often entail considerable out-of-pocket expenses for consumers. Compounding this financial barrier is the frequent absence of comprehensive coverage by health insurance providers, leaving individuals to bear the full cost. According to the College of American Pathologists, citing a February 2026 Office of Inspector General report, genetic tests accounted for 43% of all Medicare Part B lab test spending in 2024, despite representing only 5% of the total tests paid under the program. This elevated cost burden directly limits consumer willingness and ability to adopt nutrigenomics solutions, thereby constraining broader market penetration and curtailing the potential for widespread consumer engagement with personalized nutrition strategies.

Key Market Trends

AI-Driven Personalization in Nutrigenomics
The increasing integration of artificial intelligence and bioinformatics is fundamentally transforming the United States nutrigenomics market by enabling more sophisticated and precise personalized recommendations. These advanced technologies analyze vast datasets, including genomic, epigenomic, and lifestyle information, to formulate highly tailored nutritional strategies and intervention protocols. The application of AI algorithms allows for dynamic adjustments to dietary advice based on real-time health metrics and individual responses, moving beyond static, one-size-fits-all approaches. This technological advancement fosters greater accuracy in identifying genetic predispositions and optimizing nutrient intake for specific health outcomes. According to Nutraceuticals World, in December 2025, a Thorne survey revealed that 43% of respondents had used AI for health advice in the past month, highlighting growing consumer reliance on such platforms.

Genetically Informed Functional Foods and Supplements
Concurrently, the emergence of genetically informed functional foods and supplements represents a significant trend, offering tangible products directly aligned with individual genetic profiles. This trend is characterized by the development of specialized food products and dietary supplements designed to deliver targeted nutrients or bioactive compounds based on a person's unique genetic makeup. Such products aim to optimize specific physiological functions, mitigate genetic health risks, or enhance overall well-being with unprecedented specificity. This drives innovation in product formulation and expands the commercial offerings within the nutrigenomics sector. Thorne, a key player in science-backed health solutions, surpassed $500 million in annual revenue in 2025, demonstrating the substantial market for personalized and genetically relevant nutritional products.

Segmental Insights

Rapid Growth of US Nutrigenomics Cancer Research
The Cancer Research segment is demonstrating rapid growth within the United States Nutrigenomics Market, primarily driven by an evolving comprehension of the intricate interplay between dietary factors, genetic predispositions, and cancer development. This expansion is propelled by researchers actively applying nutrigenomic principles to investigate how specific nutrients and dietary patterns influence gene expression pertinent to cancer prevention, progression, and treatment efficacy. The significant potential for developing personalized dietary interventions that either reduce cancer risk or enhance existing therapeutic strategies further accelerates this growth. This focused understanding of genetic factors in oncology, supported by initiatives from institutions like the National Cancer Institute, underscores the segment's robust trajectory.

Regional Insights

West Region Leads US Nutrigenomics Market Through Biotech Ecosystem, Innovation, and Research Institutions
The West region leads the United States Nutrigenomics Market, primarily due to its robust ecosystem of biotechnology hubs and a high concentration of tech-driven healthcare companies. This area serves as a key center for innovation in nutrigenomics research, encompassing direct-to-consumer genetic testing services and advanced AI-driven personalized nutrition solutions. The region's dominance is further supported by widespread consumer awareness regarding personalized nutrition and a substantial affluent consumer base actively seeking sophisticated wellness interventions. Additionally, the presence of numerous top-tier research institutions contributes significantly to the West's foundational role in driving advancements and adoption within the nutrigenomics sector.

Recent Developments

• In July 2025, Danone North America unveiled the recipients of its 2024-2025 Annual Gut Microbiome, Yogurt and Probiotic Fellowship Program. The company awarded two $25,000 grants to graduate students at U.S. universities to support innovative research. This funding, a significant investment in the United States Nutrigenomics Market, was designated for projects aimed at deepening the scientific understanding of yogurt, probiotics, and the gut microbiome. The research initiatives are expected to explore eco-evolutionary processes within the microbiome that influence human health and identify the causes and consequences of dysbiosis, thereby contributing to the development of sustainable treatments.
• In November 2024, Persona Nutrition, a pioneer in subscription-based personalized vitamins and supplements, launched a new white-labeling service. This strategic offering allowed other businesses and personalities to enter the personalized nutrition sector by leveraging Persona's established direct-to-consumer expertise. The service provided a comprehensive, turnkey approach including customized vitamin assessments, proprietary algorithms for personalized nutrition recommendations, and access to a Drug-Nutrient Interaction Checker. This expansion within the United States Nutrigenomics Market enabled a broader adoption of science-backed, personalized health solutions, allowing more brands to offer tailored dietary supplement programs to their customer bases efficiently.
• In September 2024, GenoPalate, a prominent U.S. nutrigenomic platform, announced a collaboration with ThrivePass, a leader in personalized employee benefits. This partnership introduced personalized nutritional insights, based on individual DNA, into employee wellness programs across the United States. GenoPalate’s advanced nutrigenomic technology became integrated into the ThrivePass Marketplace, allowing employees to access tailored nutritional recommendations. This initiative underscored a growing trend within the United States Nutrigenomics Market to expand personalized health solutions beyond direct-to-consumer models, fostering better nutrition choices and personalized wellness experiences within corporate settings.
• In July 2024, Viome, a Bellevue, Washington-based wellness and diagnostics company, launched new personalized toothpaste and gel products as part of its Oral Health Solution system. This new product offering in the United States Nutrigenomics Market was developed using insights from the company’s Oral Health Intelligence test, which analyzes oral microbiome data. The aim is to help individuals understand the connection between their oral microbes and overall oral health, providing customized formulations of prebiotics, postbiotics, and other ingredients to address specific needs. The company stated that the MyBiotics Toothpaste and Gel target issues like tooth decay and gum disease by offering precision oral hygiene solutions.

Key Market Players

• 23andMe Holding Co.
• Nutrigenomix Inc.
• DNAfit Ltd.
• GX Sciences LLC
• Helix OpCo LLC
• Viome Life Sciences Inc.
• Habit LLC
• DayTwo Ltd.
• Atlas Biomed Group Limited
• GenoPalate Inc.

By Application	By Product	By Technique	By End User	By Region
Obesity Cardiovascular Diseases Cancer Research Others	Reagents & Kits Services	Saliva Buccal Swab Blood	Hospitals & Clinics Others	Northeast Midwest South West

Report Scope:

In this report, the United States Nutrigenomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• United States Nutrigenomics Market, By Application:

• Obesity
• Cardiovascular Diseases
• Cancer Research
• Others

• United States Nutrigenomics Market, By Product:

• Reagents & Kits
• Services

• United States Nutrigenomics Market, By Technique:

• Saliva
• Buccal Swab
• Blood

• United States Nutrigenomics Market, By End User:

• Hospitals & Clinics
• Others

• United States Nutrigenomics Market, By Region:

• Northeast
• Midwest
• South
• West